Relevium Announces All-Time Record High of Units Sales for Bioganix® in March

Medical Device Investing

Relevium Technologies (TSXV:RLV) is pleased to report an all-time record high in unit sales for the month of March 2018. As quoted in the press release: Abis Hussain, SMO of Relevium, stated: “The implications of this may seem trivial, but the results form this month in a seasonally low period indicate that Mach 2.0 is working as designed. We …

Relevium Technologies (TSXV:RLV) is pleased to report an all-time record high in unit sales for the month of March 2018.

As quoted in the press release:

Abis Hussain, SMO of Relevium, stated: “The implications of this may seem trivial, but the results form this month in a seasonally low period indicate that Mach 2.0 is working as designed. We expect this to also have a positive impact on new products launches over the next six months.” Aurelio Useche, CEO of Relevium, stated: “This is the first real test of the capabilities of our marketing engine following months of adjustments and beta testing. This small but important success is an important achievement for the company and for our digital marketing and operating teams.”

Click here to read the full press release.

The Conversation (0)
×